Trials / Completed
CompletedNCT05921591
Safety, Tolerability, and Pharmacokinetics of IRL201104 in Healthy Volunteers
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of IRL201104 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Revolo Biotherapeutics · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this clinical study is to assess the safety, tolerability and pharmacokinetics of repeat doses of IRL201104 given to healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IRL201104 | Lyophilised powder for reconstitution for IV dosing |
| DRUG | Placebo | Matching placebo for IRL201104 |
Timeline
- Start date
- 2023-05-26
- Primary completion
- 2023-09-12
- Completion
- 2023-09-12
- First posted
- 2023-06-27
- Last updated
- 2023-09-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05921591. Inclusion in this directory is not an endorsement.